MHRA-101882-PIP01-25

Key Facts

Active Substance
Active Substance:
  • Pentavalent mRNA vaccine encoding for NoV VP1
Invented Name
Not available at present
PIP Number MHRA-101882-PIP01-25
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Dispersion for injection
Therapeutic area
Therapeutic area:
  • Vaccines
Conditions / Indications
Conditions / Indications:
  • Prevention of norovirus acute gastroenteritis
Route(s) of administration
Route(s) of administration:
  • Intramuscular use
PIP applicant
Decision Type
Decision Type
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s)
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Pentavalent mRNA vaccine encoding for NoV VP1.pdf
Published Date 10/04/2026